Suppliers / New Horizon Pharma Us

New Horizon Pharma Us

Updated 9 July 2026

New Horizon Pharma Us is an API manufacturer. It holds 7 active US drug master files across a filed portfolio of 7 molecules.

7
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Enclomiphene US FDA 1
Gepirone US FDA 1
Inositol US FDA 1
Minoxidil US FDA 1
Nadide US FDA 1
Pitolisant US FDA 1
Salsalate US FDA 1

Also appears on these molecule pages

Questions about New Horizon Pharma Us

Does New Horizon Pharma Us hold a US DMF or a CEP?
New Horizon Pharma Us holds 7 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does New Horizon Pharma Us make?
7 molecules are on record against New Horizon Pharma Us, including Enclomiphene, Gepirone, Inositol and Minoxidil. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. New Horizon Pharma Us comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability